Key points are not available for this paper at this time.
These data suggest that, in giant, aggressive prolactinomas, CAB represents a first-line therapy effective in reducing PRL levels and determining tumour shrinkage.
Building similarity graph...
Analyzing shared references across papers
Loading...
Salvatore Maria Corsello
Graziamaria Ubertini
Maria Altomare
Clinical Endocrinology
Università Cattolica del Sacro Cuore
Catholic University of America
Building similarity graph...
Analyzing shared references across papers
Loading...
Corsello et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69de96c67ed287395e559ea5 — DOI: https://doi.org/10.1046/j.1365-2265.2003.01770.x
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: